MARATHON CAPITAL MANAGEMENT

Position in RPRX — Royalty Pharma plc

CIK 1213206 Hunt Valley, MD

Position in RPRX

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$525,039

+$94,413 QoQ

Shares Held

9,364

+4.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#392

of 644 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 6% Shared 0% None 94%

Healthcare · as of Jun 30, 2026

MARATHON CAPITAL MANAGEMENT holds $5,159,453 across 4 Biotechnology names. RPRX ranks #2 (10.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADMA	Adma Biologics, Inc.	532,353	$4,455,794
2	RPRX	Royalty Pharma plc This page	9,364	$525,039
3	DYAI	Dyadic International Inc	110,000	$99,000
4	RXRX	Recursion Pharmaceuticals, Inc.	21,695	$79,620

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$525,039	9,364	+4.3%	Shares	Sole	2026-07-22
2026-03-31	$430,626	8,977	+18.1%	Shares	Sole	2026-05-14
2025-12-31	$293,586	7,598	+4.6%	Shares	Sole	2026-01-29
2025-09-30	$256,344	7,266	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.